Delivery Order SPE2DX22D0010-SPE2D825FHE28
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,523.30 firm fixed-price contract is for the delivery of 4567438595 - Fentanyl Transdermal Patches 37.5 MCG. The award has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fentanyl Transdermal Patches, 37.5 mcg, with a ceiling value of $1,979.46 and an ultimate completion date of March 27, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a $12,483.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567480596 - Fentanyl Transdermal Patches, 37.5 mcg, with a period of performance through March 7, 2025. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide a Fentanyl Transderm Patch 37.5 MCG. The potential value of this delivery order is $6,790.03 with a completion date of February 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fentanyl 37.5 mcg/hr transdermal patches. The fixed-price contract has a ceiling value of $1,118.52 and a period of performance through May 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,283.16 firm fixed-price contract is for the provision of FENTANYL TRANSDERM PATCH 37.5MCG, a critical pain management medication. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fentanyl 37.5 MCG/HR Patch 5S, a specialty medication, and has a ceiling value of $1,507.09. The contract is a firm fixed price delivery order, with a period of performance through February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,528.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Fentanyl Transdermal Patches, a critical pharmaceutical product, to support the Department of Defense's (DoD) medical treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fentanyl Transderm Patches, a pharmaceutical product, with a ceiling value of $1,094.22 and a performance period extending to July 11, 2025. The contract is not set aside and was awarded on a firm-fixed-price basis. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a $96,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Fentanyl 100 mcg/hr patches. The one-day contract has a period of performance from July 5, 2023 through July 6, 2023. Amerisourcebergen will deliver the fentanyl patches to its Conshohocken, Pennsylvania location to support the Department of Defense's medical supply needs. No set aside designation or subcontractors were identified. This delivery order was issued against an...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHE28Delivery Order
The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl Transdermal Patch 37.5 micrograms, with a ceiling value of $1,934.74. The contract, awarded on July 25, 2025, employs firm fixed-price pricing and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999.999 billion through December 2026. No set-aside designation was utilized for this award, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical devices to military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply needs across multiple therapeutic domains. This specific delivery order supports the Defense Medical Supply Chain's pharmaceutical requirements for controlled substances and pain management medications necessary for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/25/25 |